[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Upstate Institutional Review Board (IRB) Number:

1475823

Study/Protocol ID:

S1826

Study Phase:

III

Patient Age Group:

Adults and Children

Principal Investigator:

Teresa C Gentile, MD, PhD

Who can I contact for more information?

Name: Karen B Bilynsky
Phone: 315-464-7601
Email: bilynskk@upstate.edu

Return to Previous Page || Search Again

Top